Loading results ...
 

Biostorage Blog

Designing a new social contract for healthcare

“The good physician treats the disease; the great physician treats the patient who has the disease.” William Osler, M.D., Founding member of Johns Hopkins School of Medicine There is a crucial distinction between seeing patients as clinical problems to be solved versus caring for patients as human beings and addressing the root causes of their […]

Read more »

ICH E18: Genomic Sampling Methodologies for Future Use

Many regulatory agencies (FDA, EMA, PMDA) have published guidelines encouraging genomic sample collection during drug product development.   These data may be helpful in evaluating drug safety and effectiveness in responders and non-responders, or high and low risk populations, and is increasingly included in drug labels. Nevertheless, it has been reported that the rate of genomic […]

Read more »

Genotyping Begins on NIDA’s Biorepository of over 50,000 Samples –Affymetrix, BioRealm, and RUCDR Infinite Biologics Team Up To Help Study the Genetics of Addiction

Santa Clara, CA, July 7, 2015 – Affymetrix, Inc. (NASDAQ: AFFX), BioRealm, LLC, and RUCDR Infinite Biologics today announced a broad strategic alliance. This alliance will leverage BioRealm’s SmokeScreen® platform to genotype the National Institute on Drug Abuse (NIDA) biorepository of more than 50,000 samples, collected from human subjects studied in NIDA-funded research. NIDA preserves […]

Read more »

The key to unlocking genomic medicine’s promise to human health

The combination of genomic and clinical data holds great promise for science and medicine. But in many cases, making such advances requires data from millions of samples—numbers greater than any single laboratory or institution can collect on its own. To reach that scale, genomic data must be shared on a global level. Right now, they […]

Read more »

Industry-led collaboration is a game-changer for research advancement

Despite the current healthcare market challenges ranging from a tougher environment for product reimbursement to a longer approval process for new products, to dwindling federal research dollars, there is still an overwhelming need to bring more life-saving pharmaceuticals, diagnostics and medical devices to market.  Collaboration is one way to overcome these obstacles whether they are […]

Read more »

16-20 October 2015 – World Congress on Psychiatric Genetics

BioStorage Technologies will be attending the World Congress on Psychiatric Genetics in Toronto, Canada, October 16-20, 2015. We will be with our BioProcessing Solutions Alliance partner, RUCDR Infinite Biologics. Visit us at our booth or schedule an onsite meeting. Schedule to meet with us at the event: 

Read more »

12-14 October 2015 – Biorepositories and Sample Management Summit

BioStorage Technologies will be attending the Biorepositories and Sample Management Summit in Boston, MA. Schedule an onsite meeting with one of our sample management experts! Schedule to meet with us at the event: 

Read more »

6-10 October 2015 – American Society of Human Genetics Annual Meeting

BioStorage Technologies will be attending the American Society of Human Genetics Annual Meeting in Baltimore, MD. We will be at booth #517 with our BioProcessing Solutions Alliance partner, RUCDR Infinite Biologics. Visit us at our booth or schedule an onsite meeting. Schedule to meet with us at the event: 

Read more »

24-27 June 2015 – International Society for Stem Cell Research Annual Meeting

BioStorage Technologies will be attending the International Society for Stem Cell Research Annual Meeting in Stockholm, Sweden. We will be at booth #B04:35 with our BioProcessing Solutions Alliance partner, RUCDR Infinite Biologics. Visit us at our booth or schedule an onsite meeting. Schedule to meet with us at the event: 

Read more »

Smokescreen: A platform for genetic research on smoking, addiction and treatment approaches

Addiction is a complex phenotype with many genetic and non-genetic factors influencing risk and response to treatment. To develop individualized prevention and treatment strategies, the National Institute on Drug Abuse (NIDA) saw a need for a common genotyping array specifically designed for addiction research. NIDA awarded BioRealm with a Small Business Innovative Research (SBIR) contract […]

Read more »